Literature DB >> 3559401

Characterization of the estrogen-induced lipoprotein receptor of rat liver.

A D Cooper, R Nutik, J Chen.   

Abstract

The ethinyl estradiol-induced lipoprotein receptor of rat liver was purified and characterized. Liver membranes were prepared from ethinyl estradiol-treated rats, solubilized, and subjected to DEAE chromatography. A fraction with a high specific activity for low density lipoprotein (LDL) binding was isolated and used to immunize mice. Hybridomas were prepared from their spleen cells, and a clone that secreted an IgG antibody, which cross-reacted with an ethinyl estradiol-induced protein of the same molecular weight as the bovine adrenal LDL receptor, was expanded. This antibody, designated P1B3, immunoprecipitated the induced lipoprotein receptor. P1B3 was used to purify the receptor, and a polyclonal antibody was raised against the pure protein. This antibody recognized a protein of similar molecular weight in rat liver, adult dog liver, and human skin fibroblasts, thus demonstrating that the induced rat lipoprotein receptor was related to the LDL receptor of other species. This receptor is present in normal rat liver, and its content is reduced by feeding an atherogenic diet, but not by feeding a diet containing 0.5% cholesterol. Moreover, cholestyramine supplementation of the diet did not induce the receptor on liver membranes. The polyclonal antibody could prevent the binding of LDL to liver membranes from control or ethinyl estradiol-treated rats. It decreased chylomicron remnant binding to membranes from ethinyl estradiol-treated membranes, but did not affect chylomicron remnant binding to liver membranes of untreated rats, a result compatible with the existence of a distinct receptor for these latter particles. The amount of LDL receptor-independent, specific remnant binding was the same in both control and ethinyl estradiol-treated rats. This is consistent with the concept that the remnant receptor is not regulated by this treatment. Based on the above, we conclude that the ethinyl estradiol-induced lipoprotein receptor of rat liver is biochemically and immunologically similar to the LDL receptor of other species. It is present on the liver of normal adult rats and could account for LDL as well as beta VLDL and HDLc removal. Although it may contribute to chylomicron remnant removal, there appears to be a second unrelated receptor or process which recognizes this lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559401

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

1.  The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants.

Authors:  E Windler; J Greeve; B Levkau; V Kolb-Bachofen; W Daerr; H Greten
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Beta-migrating very-low-density lipoprotein, chylomicron remnants and their receptors.

Authors:  W Liao
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

3.  Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver, and intestine.

Authors:  L G Fong; E Bonney; J C Kosek; A D Cooper
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

4.  Receptor-mediated uptake of homologous low-density lipoproteins by isolated liver parenchymal cells of fetal rats.

Authors:  U Dürer; M Sommer; H Franke; B Schlag; R Dargel
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

Review 5.  Role of Estrogens in the Regulation of Liver Lipid Metabolism.

Authors:  Brian T Palmisano; Lin Zhu; John M Stafford
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

7.  Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.

Authors:  E E Windler; J Greeve; W H Daerr; H Greten
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

8.  Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha).

Authors:  Jae Hoon Jeong; Sehyung Cho; Youngmi Kim Pak
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

9.  Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Authors:  S Y Choi; L G Fong; M J Kirven; A D Cooper
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Purification of low density lipoprotein receptor from liver and its quantification by anti-receptor monoclonal antibodies.

Authors:  E Gherardi; N Brugni; D E Bowyer
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.